Powered 500 · 2026POWEREDS. 221 of 500
Leading Moderna from a 30-person startup to an $18 billion revenue company, Bancel oversaw the fastest vaccine development in pharmaceutical history — genetic sequence to first human dose in 63 days — while scaling mRNA manufacturing to billions of doses globally.
Stéphane Bancel has been CEO of Moderna since 2011, joining when the biotech had fewer than 30 employees and no approved products.
The company's mRNA platform powered one of the two primary COVID-19 vaccines, moving from genetic sequence to first human dose in 63 days and driving peak annual revenue above $18 billion. Moderna now has more than 40 programs in its pipeline across oncology, rare diseases, and infectious diseases.
Interview · In Pipeline
Sponsored placement
An invitation, extended to Powered readers.
Drive the Continental GT S.
Request a test driveBentley T&Cs apply
